{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T04:08:41Z","timestamp":1702094921557},"reference-count":27,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2169\/internalmedicine.9482-17","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T17:25:10Z","timestamp":1513790710000},"page":"1021-1026","source":"Crossref","is-referenced-by-count":10,"title":["Chronic Brachial Plexus Neuritis That Developed into Typical Neuralgic Amyotrophy and Positively Responded to Immunotherapy"],"prefix":"10.2169","volume":"57","author":[{"given":"Ryo","family":"Morishima","sequence":"first","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utako","family":"Nagaoka","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Nagao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Isozaki","sequence":"additional","affiliation":[{"name":"Department of Neurology, Tokyo Metropolitan Neurological Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Parsonage MJ, Turner JWA. Neuralgic amyotrophy; the shoulder-girdle syndrome. Lancet 1: 973-978, 1948.","DOI":"10.1016\/S0140-6736(48)90611-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tsairis P, Dyck PJ, Mulder DW. Natural history of brachial plexus neuropathy. Arch Neurol 27: 109-117, 1972.","DOI":"10.1001\/archneur.1972.00490140013004"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Van Alfen N, van Engelen BGM. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain 129: 438-450, 2006.","DOI":"10.1093\/brain\/awh722"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Van Alfen N, van Engelen BGM. Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst Rev 8: CD006976, 2009.","DOI":"10.1002\/14651858.CD006976.pub2"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Nomoto N, Konno S, Murata M, Nakazora H, Nemoto H, Fujioka T. Case of neuralgic amyotrophy with anti GT1a antibody. Rinsho Shinkeigaku 50: 415-417, 2010 (in Japanese, Abstract in English).","DOI":"10.5692\/clinicalneurol.50.415"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Moriguchi K, Miyamoto K, Takada K, Kusunoki S. Four cases of anti-ganglioside antibody-positive neuralgic amyotrophy with good response to intravenous immunoglobulin infusion therapy. J Neuroimmunol 238: 107-109, 2011.","DOI":"10.1016\/j.jneuroim.2011.08.005"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Naito K, Fukushima K, Ikeda S, et al. Intravenous immunoglobulin (IVIg) with methylprednisolone pulse therapy for motor impairment of neuralgic amyotrophy, clinical observations in 10 cases. Intern Med 51: 1493-1500, 2012.","DOI":"10.2169\/internalmedicine.51.7049"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Nakajima M. Partial but rapid recovery from paralysis after immunomodulation during early stage of neuralgic amyotrophy. Euro Neurol 55: 227-229, 2006.","DOI":"10.1159\/000093875"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Johnson NE. Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and IVIg. Muscle Nerve 44: 304-305, 2011.","DOI":"10.1002\/mus.22100"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kuhlenbaumer G, Stogbauer F, Timmerman V, De Jonghe P. Diagnostic criteria for heredity neuralgic amyotrophy or heredofamilial neuritis with brachial plexus predilection. On behalf of the European CMT Consortium. Neuromuscul Disord 10: 515-517, 2000.","DOI":"10.1016\/S0960-8966(00)00109-7"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Van Alfen N, van Eijk JJJ, Ennik T, et al. Incidence of neuralgic amyotrophy (Parsonage Turner syndrome) in a primary care setting: a prospective cohort study. PLoS ONE 10: e0128361, 2015.","DOI":"10.1371\/journal.pone.0128361"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Flaggman PD. Brachial plexus neuropathy. An electrophysiologic evaluation. Arch Neurol 37: 160-164, 1980.","DOI":"10.1001\/archneur.1980.00500520058010"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Matsuda N, Kobayashi S, Otani K, Hasegawa O, Ugawa Y. Skeletal muscle MRI in a patient with neuralgic amyotrophy. Clin Neurol 53: 650-653, 2013.","DOI":"10.5692\/clinicalneurol.53.650"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. West GA, Haynor DR, Goodkin R, et al. Magnetic resonance imaging signal changes in denervated muscles after peripheral nerve injury. Neurosurg 35: 1077-1086, 1994.","DOI":"10.1097\/00006123-199412000-00010"},{"key":"15","unstructured":"15. Massie R, Mauermann ML, Dyck PJB, et al. Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain 135: 3074-3088, 2012."},{"key":"16","unstructured":"16. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 15: 79-92, 2010."},{"key":"17","unstructured":"17. Van den Bergh PY, Hadden RD, Bouche P, et al. European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol 17: 356-363, 2010."},{"key":"18","unstructured":"18. Erratum in: J Peripher Nerv Syst 15: 373, 2010 and in Eur J Neurol 18: 796, 2011."},{"key":"19","unstructured":"19. Koike H, Tanaka F, Sobue G. Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations. Curr Opin Neurol 24: 504-510, 2011."},{"key":"20","unstructured":"20. Suarez GA, Giannini C, Bosch EP, et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory immune pathogenesis. Neurology 46: 559-561, 1996."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Vriesendrop FJ, Dmytrenko GS, Dietrich T, Koski CL. Anti-peripheral nerve myelin antibodies and terminal activation products of complement in serum of patients with acute brachial plexus neuropathy. Arch Neurol 50: 1301-1303, 1993.","DOI":"10.1001\/archneur.1993.00540120016006"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Van Eijk JJ, van Alfen N, Tio-Gillen AP, et al. Screening for antecedent <i>Campylobacter jejuni<\/i> infections and anti-ganglioside antibodies in idiopathic neuralgic amyotrophy. J Peripher Nerv Syst 16: 153-156, 2011.","DOI":"10.1111\/j.1529-8027.2011.00339.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Stich O, Glos D, Brendle M, Dersch R, Rauer S. CSF profile and seroprevalence of antiganglioside reactivity in NA. J Peripheral Nerv Sys 21: 27-32, 2016.","DOI":"10.1111\/jns.12157"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Van Schaik IN, Nan den Berg LH, de Hann R, Vermeulen M. Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev 18: CD004429, 2005.","DOI":"10.1002\/14651858.CD004429.pub2"},{"key":"25","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1212\/01.wnl.0000234063.51897.20","volume":"67","author":"E Delmont","year":"2006","unstructured":"25. Delmont E, Azulay JP, Giorgi R, et al. Multifocal motor neuropathy with and without conduction block. Neurology 67: 592-596, 2006.","journal-title":"Neurology","ISSN":"http:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"26","unstructured":"26. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 11: 1-8, 2006."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Nobile-Orazio E, Gallia F, Terenghi F, et al. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies? J Neurol Sci 266: 156-163, 2008.","DOI":"10.1016\/j.jns.2007.09.020"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/7\/57_9482-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T06:21:57Z","timestamp":1570515717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/57\/7\/57_9482-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9482-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}